Page 61 - Demo

%u4eba%u6587%u793e%u6703%u8207%u91ab%u5b78%u7684%u8de8%u57df%u7814%u7a76%u8207%u885b%u751f%u653f%u7b56%u8f49%u8b6f%u7684%u6311%u6230%u2500%u4ee5%u7cd6%u5c3f%u75c5%u8ad6%u8cea%u8a08%u916c%u653f%u7b56%u70ba%u4f8b61%u5165%uff0c%u56e0%u6b64%u5982%u679c%u53ef%u4ee5%u900f%u904e%u6301%u7e8c%u4e26%u4e14%u7cfb%u7d71%u6027%u7814%u7a76%u4f86%u8a55%u4f30%u885b%u751f%u653f%u7b56%u7684%u6210%u6548%uff0c%u4e0d%u50c5%u53ef%u4ee5%u63d0%u4f9b%u672a%u4f86%u885b%u751f%u653f%u7b56%u898f%u5283%u6216%u5be6%u65bd%u4fee%u6b63%u7684%u53c3%u8003%uff0c%u4ea6%u53ef%u85c9%u6b64%u5be6%u8b49%u5b78%u8853%u7814%u7a76%u7d50%u679c%u4f86%u5206%u4eab%u81fa%u7063%u5728%u885b%u751f%u653f%u7b56%u5be6%u65bd%u548c%u52aa%u529b%u7684%u7d93%u9a57%u3002%u5728%u6b64%u77ed%u6587%u4e2d%uff0c%u5c07%u4ee5%u4e00%u9805%u885b%u751f%u798f%u5229%u90e8%u5be6%u65bd%u591a%u5e74%u6210%u6548%u5353%u8457%u7684%u885b%u751f%u653f%u7b56%u2015%u8ad6%u8cea%u8a08%u916c%u65b9%u6848%u70ba%u4f8b%uff0c%u5206%u4eab%u8fd1%u5e74%u6df1%u5ea6%u8de8%u57df%u7814%u7a76%u548c%u885b%u751f%u653f%u7b56%u8f49%u8b6f%u7684%u6311%u6230%u3002%u81ea 2001 %u5e74%uff0c%u4e2d%u592e%u5065%u4fdd%u7f72%u9678%u7e8c%u4ee5%u6162%u6027%u75c5%u70ba%u4e3b%u7684%u5171%u540c%u7167%u8b77%u6a21%u5f0f%u7684%u8ad6%u8cea%u8a08%u916c%u652f%u4ed8%u5236%u5ea6%uff08Pay-for-Performance%uff09%uff0c%u4f8b%u5982%u7cd6%u5c3f%u75c5%uff082001 %u5e74%uff0c%u65bc 2012 %u5e74%u7d0d%u5165%u652f%u4ed8%u6a19%u6e96%u7b2c%u516b%u90e8%u7b2c%u4e8c%u7ae0%uff09%u3001%u6c23%u5598%uff082001 %u5e74%uff09%u3001%u9ad8%u8840%u58d3%uff082006 %u5e74%uff09%u3001Pre-ESRD %u75c5%u4eba%u7167%u8b77%u8207%u885b%u6559%u8a08%u756b%uff082006 %u5e74%uff09%u3001B %u578b%u809d%u708e%u5e36%u539f%u8005%u53ca C %u578b%u809d%u708e%u611f%u67d3%uff082010 %u5e74%uff09%u3001%u601d%u89ba%u5931%u8abf%u75c7%uff082010%u5e74%uff09%u3001%u521d%u671f%u6162%u6027%u814e%u81df%u75c5%uff082011 %u5e74%uff0c%u65bc 2016 %u5e74 4 %u6708%u7d0d%u5165%u652f%u4ed8%u6a19%u6e96%u7b2c%u516b%u90e8%u7b2c%u4e09%u7ae0%uff09%u548c%u6162%u6027%u963b%u585e%u80ba%u75c5%uff082017 %u5e74 4 %u6708%uff09%u7b49%u75be%u75c5%u6539%u5584%u7b49%u524d%u77bb%u6027%u652f%u4ed8%u65b9%u5f0f%u3002%u5be6%u65bd%u4e4b%u4e3b%u8981%u76ee%u6a19%u7686%u662f%u5e0c%u671b%u80fd%u5920%u900f%u904e%u5efa%u7acb%u4ee5%u75c5%u60a3%u70ba%u4e2d%u5fc3%u7684%u5171%u540c%u7167%u8b77%u6a21%u5f0f%uff0c%u4f86%u63d0%u5347%u6cbb%u7642%u6307%u5f15%u9075%u5faa%u7387%u548c%u63d0%u5347%u91ab%u7642%u54c1%u8cea%u4e26%u5efa%u7acb%u4ee5%u63d0%u5347%u91ab%u7642%u54c1%u8cea%u70ba%u5c0e%u5411%u7d66%u4ed8%u6539%u5584%u5236%u5ea6%uff08%u8b1d%u6167%u654f%u7b49%uff0c2014%uff1bHsieh et al., 2016a; Chen et al., 2021; Lee et al., 2019%uff09%u3002%u8ad6%u8cea%u8a08%u916c%u652f%u4ed8%u5236%u5ea6%u5be6%u65bd%u7684%u4e3b%u8981%u76ee%u6a19%u662f%u5e0c%u671b%u80fd%u5920%u900f%u904e%u5efa%u7acb%u300c%u4ee5%u75c5%u4eba%u70ba%u4e2d%u5fc3%u300d%u7684%u5171%u540c%u7167%u8b77%u6a21%u5f0f%uff0c%u4ee5%u63d0%u5347%u91ab%u7642%u54c1%u8cea%u4e26%u5efa%u7acb%u826f%u597d%u7684%u54c1%u8cea%u5c0e%u5411%u652f%u4ed8%u5236%u5ea6%uff08Hsieh et al., 2016b%uff09%u3002%u8a31%u591a%u570b%u5bb6%uff08%u5982%u82f1%u570b%u3001%u7f8e%u570b%u7b49%uff09%u958b%u59cb%u5be6%u65bd%u8ad6%u8cea%u8a08%u916c%u652f%u4ed8%u5236%u5ea6%uff0c%u900f%u904e%u7d66%u4ed8%u91ab%u7642%u670d%u52d9%u63d0%u4f9b%u8005%u9069%u7576%u7684%u8ca1%u52d9%u8a98%u56e0%uff0c%u9f13%u52f5%u91ab%u7642%u63d0%u4f9b%u8005%u7d66%u4e88%u75c5%u4eba%u66f4%u59a5%u5584%u7684%u7167%u8b77%uff08Eijkenaar et al., 2013; Gillam et al., 2012; Mendelson et al., 2017%uff09%u3002%u4ee5%u7cd6%u5c3f%u75c5%u8ad6%u8cea%u8a08%u916c%u652f%u4ed8%u5236%u5ea6%u70ba%u4f8b%uff0c%u8a72%u9805%u8ad6%u8cea%u8a08%u916c%u5236%u5ea6%u662f%u76ee%u524d%u81fa%u7063%u76f8%u95dc%u8ad6%u6587%u767c%u8868%u6700%u591a%uff0c%u4e14%u9817%u5177%u6b63%u5411%u6548%u76ca%u7684%u652f%u4ed8%u5236%u5ea6%uff08Hsieh et al., 2015a; Hsieh et al., 2016b; Hsieh et al., 2016c%uff09%u3002 %u56e0 %u70ba %u7814 %u7a76 %u8208 %u8da3%uff0c %u6211 %u66fe %u7d93 %u900f %u904e %u4ee5 %u95dc %u9375 %u5b57 %u201cPay-forPerformance%u201d%u3001%u201cTaiwan%u201d %u641c%u5c0b%u5728 PUBMED %u8cc7%u6599%u5eab%u7684%u82f1%u6587%u671f%u520a%u767c%u8868%uff0c%u5f59%u6574 2010 %u5e74%u81f3 2019 %u5e74%u9593%u570b%u5167%u5404%u75be%u75c5%u8ad6%u8cea%u8a08%u916c%u8a55%u4f30%u7814%u7a76%u767c%u8868%u5171%u8a08 41 %u7bc7%uff0c%u5176%u4e2d%u4ee5%u7cd6%u5c3f%u75c5%u75be%u75c5%u7167%u8b77%u8a55%u4f30%u70ba%u6700%u591a%uff0c%u5171%u5360%u5176%u4e2d%u7684 32 %u7bc7%u3002%u7cd6%u5c3f%u75c5%u8ad6%u8cea%u8a08%u916c%u652f%u4ed8%u5236%u5ea6%u4e4b%u5168%u540d%u70ba%u300c%u5168%u6c11%u5065%u5eb7%u4fdd%u96aa%u7cd6%u5c3f%u75c5%u91ab%u7642%u7d66%u4ed8%u6539%u5584%u65b9%u6848%u300d%uff0c%u65bc 2001 %u5e74 11 %u6708%u958b%u59cb%u5be6%u65bd%uff0c%u4e26%u65bc 2012 %u5e7410 %u6708 1 %u65e5%u7d0d%u5165%u652f%u4ed8%u6a19%u6e96%u7b2c%u516b%u90e8%u7b2c%u4e8c%u7ae0%uff08%u885b%u751f%u798f%u5229%u90e8%u4e2d%u592e%u5065%u5eb7%u4fdd%u96aa%u7f72%uff0c2013%uff09%u3002%u6b64%u9805%u8ad6%u8cea%u8a08%u916c%u65b9%u5f0f%u4e3b%u8981%u63a1%u53d6%u9054%u6210%u7167%u8b77%u6307%u5f15%uff08guideline%uff09%u7684%u5305%u88f9%u5f0f%u652f%u4ed8%u5236%u5ea6%uff0c%u4e5f%u5c31%u662f%u91ab%u7642%u63d0%u4f9b%u8005%u9700%u9054%u5230%u63d0%u4f9b%u53c3%u52a0%u65b9%u6848%u7684%u7cd6%u5c3f%u75c5%u75c5%u4eba%u5b8c%u6574%u7684%u7167%u8b77%u4ecb%u5165%u63aa%u65bd%uff0c%u5373%u7d66%u4e88%u9069%u7576%u7684%u734e%u52f5%u3002%u5b8c%u6574%u7684%u7167%u8b77%u4ecb%u5165%u63aa%u65bd%u5167%u5bb9%u5305%u62ec%u4e94%u5927%u90e8%u5206%uff1a%uff081%uff09%u77ad%u89e3%u75c5%u4eba%u91ab%u7642%u75c5%u53f2%uff08medical history%uff09%uff1a%u5982%u8a55%u4f30%u6cbb%u7642%u578b%u614b%u3001%u4f4e%u6216%u9ad8%u8840%u7cd6%u7684%u983b%u7387%uff0f%u56b4%u91cd%u5ea6%u3001%u5176%u4ed6%u91ab%u7642%u75be%u75c5%u3001%u83f8%u9152%u7684%u4f7f%u7528%u7b49%uff1b%uff082%uff09%u8eab%u9ad4%u6aa2%u67e5%u8a55%u4f30%uff08physical examination%uff09%uff1a%u5982%u8840%u58d3%u3001%u8db3%u90e8%u6aa2%u67e5%u7b49%uff1b%uff083%uff09%u6aa2%u9a57%u8a55%u503c%u8a55%u4f30%uff08laboratory evaluation%uff09%uff1a%u5982 HbA1c%u3001blood sugar%u3001lipid